BAL PHARMA LTD. SHARE PRICE [LIVE]

BSE: INE083D01012   NSE: BALPHARMA   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
99.15
Change:
BSE
99.40
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in BAL PHARMA LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

BALPHARMA News

Frequently Asked Questions

What is the Share price of BAL PHARMA LTD. (BALPHARMA)?

BAL PHARMA LTD. (BALPHARMA) share price as of August 5, 2022, on NSE is Rs 99.15 (NSE) and Rs 99.40 (BSE) on BSE.

Can I buy BAL PHARMA LTD. (BALPHARMA) shares?

Yes, You can buy BAL PHARMA LTD. (BALPHARMA) shares by opening a Demat account with Angel One.

How do I buy BAL PHARMA LTD. (BALPHARMA) from Angel One?

BAL PHARMA LTD. (BALPHARMA) share can be brought through the following modes:
  1. Direct investment: You can buy BAL PHARMA LTD. (BALPHARMA) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to BAL PHARMA LTD. (BALPHARMA) shares.

In which sector do BAL PHARMA LTD. (BALPHARMA) belong?

BAL PHARMA LTD. (BALPHARMA) belongs to Pharma.

About BALPHARMA

Today's live share price for BAL PHARMA LTD. is NSE: ₹ 99.15, BSE: ₹ 99.40 with a current market capitalization of .

Bal Pharma (BPL), a member of the Mcro Laboratories group, was incorporated as a private limited company in May '87. In Mar.'90, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc. The company promotes its products through the common sales force of the group but proposes to induct its own soon. It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations. During 1997-98, the formalities of takeover of the unit from Lakme Limited have been completed and effective from 23rd July, 1997 the unit has become a division of Bal Pharma Limited. The company's product range has been expanded with the introduction of AZIWIN, CAFIMOL & CORTIDERM. The company has added further product range Zanovid, Aziwin, Dry Syrup, Meloxi, Ocium - M, Progit - MPS in its ethical division during 1999-2000. As part of the expansion of the product range, the company has introduced Cardiac Specialities Products. To market these products, a new division named "SERVETUS" has started functioning during 2001. New products like Amiloride,Benzydamine and Ebastine were rolled into the market during 2002.

Read more